Rates of opioid prescription use is higher among patients with cancer compared with patients who have never had cancer, even after survivorship.
Novel intervention focuses on caregivers' beliefs, knowledge, and skills regarding home care for patients with cancer resulting in improved pain management and better overall care at the end of life.
Results of a recent study showed that neuropathic cancer pain (NCP) in patients with cancer was not only associated with a worsened quality of life but is also not adequately managed.
Comprehensive After Surgery Recovery Program Reduces Complication Rates and Improves Surgical OutcomesMay 24, 2017
Postoperative program improves complication rates, opioid prescribing, and hospital mortality and increases home discharge rates after colorectal or hip fracture surgery.
Patient expectations, clinician perception, and institutional objectives create a perfect storm of conflicting interests regarding pain management, especially given the current trend to control opioid use.
Nurse-led project at an urban outpatient radiation oncology center not only achieved improved patient satisfaction regarding pain management.
Despite recent new legislation, medical marijuana as an adjunct to palliative and end-of-life care remains controversial. But a greater acceptance within both the medical community and the lay public is prompting research on how it can be integrated into standard care.
Perioperative Pain Control Reduces Need for Postoperative Narcotics After Hysterectomy for Uterine CancerMarch 15, 2017
Preoperative intravenous acetaminophen plus local infiltration of LB during hysterectomy and surgical staging of uterine cancer may reduce the need for postoperative narcotics.
Perioperative celecoxib use during hysterectomy may reduce the need for oral narcotics after hospital discharge.
Nearly 3 in 10 cervical cancer survivors were still using opioids at 6 months after completing radiotherapy.
Nicotinamide riboside, a type of B3 vitamin, was shown to prevent chemotherapy-induced peripheral neuropathy in an animal-model study.
A single 8-Gy dose of radiotherapy for painful bone metastases may improve quality of life and pain as early as 10 days after administration.
Sublingual fentanyl tablets were not noninferior to subcutaneous morphine for the treatment of severe pain episodes in patients with cancer.
Sublingual fentanyl is used to manage breakthrough pain in adults with cancer who are already receiving opioid therapy for underlying persistent cancer pain. In this study, researchers evaluated the effect of low doses of sublingual fentanyl in patients who are receiving low opioid doses for background analgesia.
Almost 15 percent of older adults surveyed used high-risk methods for obtaining prescription opioids, according to a recent study.
Approaches such as acupuncture, massage, and tai chi may ease discomfort when other therapy fails.
Pain response—sensitivity and tolerance—after use of active cannabis differs between men and women.
Methadone appears to be superior to fentanyl for the treatment of neuropathic pain in patients with head and neck cancer.
Recurrent disease, second malignancy, late-onset treatment effects should be assessed in patients with new pain, according to the new guidelines.
Risk factors for chronic pain after breast cancer surgery include axillary lymph node dissection, younger age, and radiation therapy. Only axillary lymph node dissection is a high-yield target for a modifiable risk factor to prevent the persistent pain after breast cancer surgery.
Managing pain with opioids and keeping a close eye on adverse effects is an important part of cancer care. But there is room for improvement in pain management tools, and nurses play a key role in their evolution.
Health experts note that opioids are prescribed too often, possibly because of poor training, and U.S. medical schools are expanding training to address the issue.
Quality of life for patients with oral cancer can be dismal due to cancer-related pain. An NIDCR grant is supporting the investigation of a nonviral gene delivery method for treating oral cancer pain safely and effectively.
ASCO Statement Seeks to Balance Prescription Opioids for Patients With Cancer and Misuse and Abuse PreventionMay 31, 2016
ASCO addresses the complex issues surrounding prescription opioids in a new policy statement. ASCO supports the efforts of multiple federal offices and agencies to prevent and respond to prescription drug abuse, and is also working to protect access to appropriate medical opioid therapy for patients with cancer.
Recent research using rats indicates that gene therapy might treat the neuropathic pain that affects 90% of patients with cancer.
All opioids are currently recommended for breakthrough cancer pain and clinicians may use the opioid of their choice.
Treatment of breakthrough cancer pain is an important component of care for patients, and nurses should consider various factors when titrating the dose of fentanyl sublingual spray to an effective dose.
Nasal spray effectively relieves intense breakthrough pain associated with radiotherapy planning and treatment.
Neurofeedback Training Enables Cancer Survivors to Control Chemotherapy-Induced Peripheral NeuropathyApril 01, 2016
Chronic pain was decreased and quality of life was increased through neurofeedback.
Providing your patient with the opportunity to tell his or her story helps to ensure that the goals of treatment are defined and met.
- Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer
- Coping With Lymphedema: A Patient Guide (Fact Sheet)
- Inotuzumab Ozogamicin Granted FDA Approval for Acute Lymphoblastic Leukemia
- Cabazitaxel in Prostate Cancer: Reduced Dose Noninferior to Standard Dose
- Risk of Some Cancers Higher in Women With a History of Periodontal Disease
- To Better Serve Patients With Cancer, Navigators Need Better Systems
- Physical Activity Improves Cognitive Function for Breast Cancer Survivors
- Risk of Lung Cancer Increases With Diets Higher in Saturated Fats
- Mechanisms Identified for Curcumin Resensitization of Cancer Cells
- Value of Type and Crossmatch Prior to Daratumumab Administration
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|